![](/img/cover-not-exists.png)
Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX
Peixoto, Renata D., Ho, Maria, Renouf, Daniel J., Lim, Howard J., Gill, Sharlene, Ruan, Jenny Y., Cheung, Winson Y.Language:
english
Journal:
American Journal of Clinical Oncology
DOI:
10.1097/coc.0000000000000193
Date:
April, 2015
File:
PDF, 150 KB
english, 2015